LRRK2 and Parkinson disease: Asymptomatic LRRK2 carriers and PD patients showed significant negative correlations between MDS-UPDRS-III scores and Cvol (Fig. 4), whereas the HCs showed significant negative correlations between MDS-UPDRS-III scores and CNR.